Stockhub

Poniard Pharmaceuticals, Inc.: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

20 August 2022

13 August 2022

10 August 2022

  • curprev 02:1102:11, 10 August 2022‎ 109.180.50.163 talk‎ 903 bytes +903‎ Created page with "Poniard Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of cancer therapeutics. Its lead platform product candidate includes Picoplatin, a platinum-based cancer therapy to treat multiple cancer indications, including small cell lung, colorectal, prostate, and ovarian cancers. The company has conducted a pivotal Phase III SPEAR trial of Picoplatin in the second-line treatment of patients with small cell lung cancer; Pha..." Tag: Visual edit
Retrieved from ‘https://stockhub.co/research/Poniard_Pharmaceuticals,_Inc.’